BACKGROUND: The goal of the present study is to identify the effect of nicotine on auditory automatic processing, as reflected by mismatch negativity (MMN), in nonsmoking schizophrenic patients. METHODS:Ten nonsmoking schizophrenic patients and 10 healthy volunteers underwent a reference session and 2 test sessions. The test sessions involved administration of a placebo patch and a nicotine skin patch, which were counterbalanced. Nicotine was administered transdermally under controlled dosage. RESULTS:Nicotine administration shortened the MMN latencies (at Fz on nicotine/placebo: 134.8 +/- 5.7/157.6 +/- 6.4 ms) in healthy volunteers. In contrast, there were no significant differences in MMN latencies in schizophrenic patients (169.6 +/- 5.7/165.0 +/- 6.4 ms). CONCLUSION:Nicotine activates and accelerates preattentive and automatic processing in healthy controls, whereas there were no such effects observed in nonsmoking patients. The impaired MMN response to nicotine administration in nonsmoking schizophrenic patients may be attributed to low nicotinic receptor function, implicated in dysregulation of the glutamatergic system. 2007 S. Karger AG, Basel
RCT Entities:
BACKGROUND: The goal of the present study is to identify the effect of nicotine on auditory automatic processing, as reflected by mismatch negativity (MMN), in nonsmoking schizophrenicpatients. METHODS: Ten nonsmoking schizophrenicpatients and 10 healthy volunteers underwent a reference session and 2 test sessions. The test sessions involved administration of a placebo patch and a nicotine skin patch, which were counterbalanced. Nicotine was administered transdermally under controlled dosage. RESULTS:Nicotine administration shortened the MMN latencies (at Fz on nicotine/placebo: 134.8 +/- 5.7/157.6 +/- 6.4 ms) in healthy volunteers. In contrast, there were no significant differences in MMN latencies in schizophrenicpatients (169.6 +/- 5.7/165.0 +/- 6.4 ms). CONCLUSION:Nicotine activates and accelerates preattentive and automatic processing in healthy controls, whereas there were no such effects observed in nonsmoking patients. The impaired MMN response to nicotine administration in nonsmoking schizophrenicpatients may be attributed to low nicotinic receptor function, implicated in dysregulation of the glutamatergic system. 2007 S. Karger AG, Basel
Authors: Nicole Pesa; Daniel F Hermens; Robert A Battisti; Manreena Kaur; Ian B Hickie; Nadia Solowij Journal: Psychopharmacology (Berl) Date: 2012-03-09 Impact factor: 4.530
Authors: Holly K Hamilton; Deepak C D'Souza; Judith M Ford; Brian J Roach; Naomi S Kort; Kyung-Heup Ahn; Savita Bhakta; Mohini Ranganathan; Daniel H Mathalon Journal: Schizophr Res Date: 2017-07-12 Impact factor: 4.939
Authors: Michael Avissar; Shanghong Xie; Blair Vail; Javier Lopez-Calderon; Yuanjia Wang; Daniel C Javitt Journal: Schizophr Res Date: 2017-07-11 Impact factor: 4.939
Authors: Gregory A Light; Neal R Swerdlow; Michael L Thomas; Monica E Calkins; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Marlena Pela; Allen D Radant; Larry J Seidman; Richard F Sharp; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; David L Braff; Bruce I Turetsky Journal: Schizophr Res Date: 2014-10-23 Impact factor: 4.939